SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-755346
Filing Date
2016-11-01
Accepted
2016-11-01 16:14:02
Documents
3
Period of Report
2016-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d83845d8k.htm 8-K 14521
2 EX-99.1 d83845dex991.htm EX-99.1 37796
3 GRAPHIC g838451.jpg GRAPHIC 9009
  Complete submission text file 0001193125-16-755346.txt   65914
Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37766 | Film No.: 161964923
SIC: 2835 In Vitro & In Vivo Diagnostic Substances